Fatigue Severity Scale: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<div class="editorbox"> | | ||
'''Original Editor '''- | <div class="editorbox"> | ||
'''Original Editor '''- [[User:Sinead Greenan|Sinead Greenan]] | |||
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | '''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | ||
</div> | </div> | ||
== Objective<br> == | == Objective<br> == | ||
The '''Fatigue Severity Scale''' is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders | The '''Fatigue Severity Scale''' is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders | ||
== Intended Population<br> == | == Intended Population<br> == | ||
Those with a variety of diagnoses including arthritis, fibromyalgia, geriatrics, multiple sclerosis, Parkinson’s disease, stroke | Those with a variety of diagnoses including arthritis, fibromyalgia, geriatrics, multiple sclerosis, Parkinson’s disease, stroke | ||
== Method of Use == | == Method of Use == | ||
*A 9 item questionnaire with questions related to how fatigue interferes with certain activities and rates its severity. | *A 9 item questionnaire with questions related to how fatigue interferes with certain activities and rates its severity. | ||
*The items are scored on a 7 point scale with 1 = strongly disagree and 7= strongly agree. | *The items are scored on a 7 point scale with 1 = strongly disagree and 7= strongly agree. | ||
*The minimum score = 9 and maximum score possible = 63. Higher the score = greater fatigue severity. | *The minimum score = 9 and maximum score possible = 63. Higher the score = greater fatigue severity. | ||
*Another way of scoring: mean of all the scores with minimum score being 1 and maximum score being 7. | *Another way of scoring: mean of all the scores with minimum score being 1 and maximum score being 7. | ||
*Self report scale. | *Self report scale. | ||
Line 30: | Line 27: | ||
=== Reliability === | === Reliability === | ||
<u>Test-retest Reliability</u> | <u>Test-retest Reliability</u> | ||
<u></u>'''Parkinson's Disease:''' | <u></u>'''Parkinson's Disease:''' | ||
(Valderramas et al, 2012; n = 30, mean age = 62 (11) years, mean time post- PD = 7.6 (6.5) years) <ref name="Valderramas et al">Valderramas, S., Feres, A. C., et al. "Reliability and validity study of a Brazilian-Portuguese version of the fatigue severity scale in Parkinson's disease patients." Arq Neuropsiquiatr 2012 70(7): 497-500</ref> | (Valderramas et al, 2012; n = 30, mean age = 62 (11) years, mean time post- PD = 7.6 (6.5) years) <ref name="Valderramas et al">Valderramas, S., Feres, A. C., et al. "Reliability and validity study of a Brazilian-Portuguese version of the fatigue severity scale in Parkinson's disease patients." Arq Neuropsiquiatr 2012 70(7): 497-500</ref> | ||
*The evaluation of the FSS-BR (Fatigue Severity Scale-Brazilian-Portuguese version) suggests an excellent Test-retest reliability (ICC = 0.91) | *The evaluation of the FSS-BR (Fatigue Severity Scale-Brazilian-Portuguese version) suggests an excellent Test-retest reliability (ICC = 0.91) | ||
<u>Interrater/Intrarater Reliability</u> | <u>Interrater/Intrarater Reliability</u> | ||
<u></u>Not established | <u></u>Not established | ||
=== Validity === | === Validity === | ||
<u>Criterion Validity (Predictive/Concurrent)</u> | <u>Criterion Validity (Predictive/Concurrent)</u> | ||
<u></u>Not established | <u></u>Not established | ||
<u>Construct Validity (Convergent/Discriminant)</u> | <u>Construct Validity (Convergent/Discriminant)</u> | ||
<u></u>'''Convergent Validity:''' | <u></u>'''Convergent Validity:''' | ||
'''Parkinson’s Disease:''' | '''Parkinson’s Disease:''' | ||
*Excellent (r = -0.77) negative correlation with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale (Hagell et al, 2006) <ref name="Hagell et al">Hagell, P., Hoglund, A., et al. "Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires." J Pain Symptom Manage 2006 32(5): 420-432</ref> | *Excellent (r = -0.77) negative correlation with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale (Hagell et al, 2006) <ref name="Hagell et al">Hagell, P., Hoglund, A., et al. "Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires." J Pain Symptom Manage 2006 32(5): 420-432</ref> | ||
*Excellent (r = 0.62) correlation with Nottingham Health Profile (NHP-EN) scale (Hagell et al, 2006) | *Excellent (r = 0.62) correlation with Nottingham Health Profile (NHP-EN) scale (Hagell et al, 2006) | ||
*Excellent (r = 0.84) correlation with Parkinson’s Fatigue (PFS) scale (Grace et al, 2006) <ref name="Grace et al">Grace, J., Mendelsohn, A., et al. "A comparison of fatigue measures in Parkinson's disease." Parkinsonism Relat Disord 2007 13(7): 443-445</ref> | *Excellent (r = 0.84) correlation with Parkinson’s Fatigue (PFS) scale (Grace et al, 2006) <ref name="Grace et al">Grace, J., Mendelsohn, A., et al. "A comparison of fatigue measures in Parkinson's disease." Parkinsonism Relat Disord 2007 13(7): 443-445</ref> | ||
*Poor-adequate (r = 0.22-0.47) correlation with Parkinson’s Disease Questionnaire-39 (PDQ-39) scale (Herlofson et al, 2003; n = 66, mean age = 70.8 (9.9) years, time since PD = 70.2 (56.1) months) <ref name="Herlofson">Herlofson, K. and Larsen, J. P. "The influence of fatigue on health-related quality of life in patients with Parkinson's disease." Acta Neurol Scand 2003 107(1): 1-6</ref> | *Poor-adequate (r = 0.22-0.47) correlation with Parkinson’s Disease Questionnaire-39 (PDQ-39) scale (Herlofson et al, 2003; n = 66, mean age = 70.8 (9.9) years, time since PD = 70.2 (56.1) months) <ref name="Herlofson">Herlofson, K. and Larsen, J. P. "The influence of fatigue on health-related quality of life in patients with Parkinson's disease." Acta Neurol Scand 2003 107(1): 1-6</ref> | ||
=== Responsiveness === | === Responsiveness === | ||
Parkinson’s Disease: | Parkinson’s Disease: | ||
Responsiveness to Pharmocological Intervention Mendoca et al, 2007; n = 17 treatment arm, receiving methyphenidate; mean age = 62.2(10), mean H&Y Stage = 2.58(0.5); n = 19 placebo arm, mean age = 66.3(7.6), mean H&Y Stage = 2.38(0.3) | Responsiveness to Pharmocological Intervention Mendoca et al, 2007; n = 17 treatment arm, receiving methyphenidate; mean age = 62.2(10), mean H&Y Stage = 2.58(0.5); n = 19 placebo arm, mean age = 66.3(7.6), mean H&Y Stage = 2.38(0.3) | ||
*Those persons in the treatment arm had a significant (p < 0.04) reduction in FSS Score by 6.5 points (from FSS = 43.8 at baseline); Cohen’s d = 0.79 | *Those persons in the treatment arm had a significant (p < 0.04) reduction in FSS Score by 6.5 points (from FSS = 43.8 at baseline); Cohen’s d = 0.79 | ||
*Smaller reductions in the placebo group did not reach levels of significance Response to Exercise Intervention: Winward et al, 2010; H&Y 0-4. n = 20 exercise group, mean age = 63.4(6.7); n = 19 control group, mean age = 64.9(9.6) | *Smaller reductions in the placebo group did not reach levels of significance Response to Exercise Intervention: Winward et al, 2010; H&Y 0-4. n = 20 exercise group, mean age = 63.4(6.7); n = 19 control group, mean age = 64.9(9.6) | ||
*No significant difference in score reduction between exercise and control group at 12 weeks | *No significant difference in score reduction between exercise and control group at 12 weeks | ||
=== Miscellaneous | === Miscellaneous<br> === | ||
== Links == | == Links == | ||
[http://www.saintalphonsus.org/documents/boise/sleep-Fatigue-Severity-Scale.pdf Fatigue Severity Scale] | [http://www.saintalphonsus.org/documents/boise/sleep-Fatigue-Severity-Scale.pdf Fatigue Severity Scale] | ||
== Recent Related Research (from [http://www.ncbi.nlm.nih.gov/pubmed/ Pubmed]) == | == Recent Related Research (from [http://www.ncbi.nlm.nih.gov/pubmed/ Pubmed]) == | ||
Line 83: | Line 80: | ||
References will automatically be added here, see [[Adding References|adding references tutorial]]. | References will automatically be added here, see [[Adding References|adding references tutorial]]. | ||
<references /> | <references /> | ||
[[Category:Outcome_Measures]] |
Revision as of 12:16, 4 September 2014
Original Editor - Sinead Greenan
Top Contributors - Sinead Greenan, Kim Jackson, Lauren Lopez, Laura Ritchie, Lucinda hampton, Evan Thomas, WikiSysop, Vidya Acharya, Candace Goh, Claire Knott and Wanda van Niekerk
Objective
[edit | edit source]
The Fatigue Severity Scale is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders
Intended Population
[edit | edit source]
Those with a variety of diagnoses including arthritis, fibromyalgia, geriatrics, multiple sclerosis, Parkinson’s disease, stroke
Method of Use[edit | edit source]
- A 9 item questionnaire with questions related to how fatigue interferes with certain activities and rates its severity.
- The items are scored on a 7 point scale with 1 = strongly disagree and 7= strongly agree.
- The minimum score = 9 and maximum score possible = 63. Higher the score = greater fatigue severity.
- Another way of scoring: mean of all the scores with minimum score being 1 and maximum score being 7.
- Self report scale.
Reference
[edit | edit source]
Evidence[edit | edit source]
Reliability[edit | edit source]
Test-retest Reliability
Parkinson's Disease:
(Valderramas et al, 2012; n = 30, mean age = 62 (11) years, mean time post- PD = 7.6 (6.5) years) [1]
- The evaluation of the FSS-BR (Fatigue Severity Scale-Brazilian-Portuguese version) suggests an excellent Test-retest reliability (ICC = 0.91)
Interrater/Intrarater Reliability
Not established
Validity[edit | edit source]
Criterion Validity (Predictive/Concurrent)
Not established
Construct Validity (Convergent/Discriminant)
Convergent Validity:
Parkinson’s Disease:
- Excellent (r = -0.77) negative correlation with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale (Hagell et al, 2006) [2]
- Excellent (r = 0.62) correlation with Nottingham Health Profile (NHP-EN) scale (Hagell et al, 2006)
- Excellent (r = 0.84) correlation with Parkinson’s Fatigue (PFS) scale (Grace et al, 2006) [3]
- Poor-adequate (r = 0.22-0.47) correlation with Parkinson’s Disease Questionnaire-39 (PDQ-39) scale (Herlofson et al, 2003; n = 66, mean age = 70.8 (9.9) years, time since PD = 70.2 (56.1) months) [4]
Responsiveness[edit | edit source]
Parkinson’s Disease:
Responsiveness to Pharmocological Intervention Mendoca et al, 2007; n = 17 treatment arm, receiving methyphenidate; mean age = 62.2(10), mean H&Y Stage = 2.58(0.5); n = 19 placebo arm, mean age = 66.3(7.6), mean H&Y Stage = 2.38(0.3)
- Those persons in the treatment arm had a significant (p < 0.04) reduction in FSS Score by 6.5 points (from FSS = 43.8 at baseline); Cohen’s d = 0.79
- Smaller reductions in the placebo group did not reach levels of significance Response to Exercise Intervention: Winward et al, 2010; H&Y 0-4. n = 20 exercise group, mean age = 63.4(6.7); n = 19 control group, mean age = 64.9(9.6)
- No significant difference in score reduction between exercise and control group at 12 weeks
Miscellaneous
[edit | edit source]
Links[edit | edit source]
Recent Related Research (from Pubmed)[edit | edit source]
Extension:RSS -- Error: Not a valid URL: Feed goes here!!|charset=UTF-8|short|max=10
References[edit | edit source]
References will automatically be added here, see adding references tutorial.
- ↑ Valderramas, S., Feres, A. C., et al. "Reliability and validity study of a Brazilian-Portuguese version of the fatigue severity scale in Parkinson's disease patients." Arq Neuropsiquiatr 2012 70(7): 497-500
- ↑ Hagell, P., Hoglund, A., et al. "Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires." J Pain Symptom Manage 2006 32(5): 420-432
- ↑ Grace, J., Mendelsohn, A., et al. "A comparison of fatigue measures in Parkinson's disease." Parkinsonism Relat Disord 2007 13(7): 443-445
- ↑ Herlofson, K. and Larsen, J. P. "The influence of fatigue on health-related quality of life in patients with Parkinson's disease." Acta Neurol Scand 2003 107(1): 1-6